AMPK	AMP-activated protein kinase
BMI	Body mass index
BP	Blood pressure
DPP	Diabetes Prevention Program
DPP-4	Dipeptidyl peptidase 4
DURATION	Diabetes therapy Utilization: Researching changes in A1C, weight and other factors
DURATION-Neo-1	DURATION-Neoadjuvant-1
EMA	European Medicines Agency
FDA	Food and Drug Administration
FGF21	Fibroblast growth factor 21
FPG	Fasting plasma glucose
HbA1c	Hemoglobin A1c
GIP	Gastric inhibitory peptide
GLP-1	Glucagon-like peptide-1
LEAD	Liraglutide Effect and Action in Diabetes
SGLT-2	Sodium-dependent glucose cotransporter proteins-2
T2DM	Type 2 diabetes mellitus
WHO	World Health Organization